BioRay’s CytoFlora Reduces Digestive and Behavioral Issues in Autistic Children


Debuts at Autism One May 22 – 25, 2009

CytoFlora decreases IgA and IgM antibodies to intestinal bacteria in children with immune disorders and autism.

LAGUNA HILLS, Calif., May 19 /PRNewswire/ — It is believed that as many as 75% of autistic children are affected by gastrointestinal dysfunction. BioRay’s new cell wall lysed probiotic, CytoFlora, has been shown in clinical testing to correct microbial imbalances, drive pathogens out of the gastrointestinal tract and assist re-colonization of healthy bowel flora. Improving digestive health is imperative for those with autism spectrum disorder (ASD). Research suggests a strong link between characteristics of ASD and impaired digestion, particularly with foods containing gluten and casein.

In a 35-day study of ten autistic children, Immunobilan testing by VIP Dx Laboratory measured immunoglobulins A (IgA) and M (IgM), two antibodies that a play critical role in immune system response. Baseline results showed elevated IgA and IgM levels, signifying an immune response to bacteria and “leaky gut”. At completion results revealed a 55% overall decrease in IgA levels and a 27% decrease in IgM levels.

Parents of study participants initially reported a variety of symptoms, including food sensitivities, yellow teeth, hyperactivity, lethargy, irrational behavior, constipation, diarrhea, anxiety, detachment from their environment, and an inability to communicate verbally and nonverbally. After 21 days on CytoFlora, scores on the Autism Treatment Evaluation Checklist, which measures Communication, Sociability, Cognitive Awareness, and Health/Physical/Behavior, indicated a 30% overall improvement.

Until now, antibiotics have been the only recognized treatment for elevated bacteria and gastrointestinal inflammation. “We see many Chronic Fatigue and Multiple Chemical Sensitivity patients in our laboratory with elevated IgA and IgM. Most are put on antibiotics for eight months followed by a course of probiotics,” noted Craig Setter of VIP Dx Laboratory. “CytoFlora results represent the first time I have seen this kind of decrease in IgA and IgM in only a few short weeks.”

BioRay will launch CytoFlora at Autism One in Chicago, the world’s foremost conference on autism, alongside presentations by actress Jenny McCarthy, author and physician Kenneth Bock, and many leading specialists in the field of autism research and treatment.

About Melissa

Melissa is the mother of two children on the autism spectrum and strives to provide information about all aspects of autism through her blog, The Autism Education Site. Follow Melissa on Twitter. Like me on Facebook.

© Melissa Hincha-Ownby and The Autism Education Site, 2008-2014.